Indication
Decrease of elevated intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient IOP reduction.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- SimbrinzaCanada · 0.2 % / W/V + 1 % / W/V · Suspension · Novartis Pharmaceuticals Canada INCSame brand
- SIMBRINZA 10mg/ml + 2mg/ml colirio en suspensionSpain · 10 mg + 2 mg · colirio en suspensión · Novartis Europharm LimitedSame brand
- SimbrinzaCroatiaSame brand
- SIMBRINZA 10 mg/ml + 2 mg/ml oogdruppels, suspensieNetherlands · Oogdruppels, suspensie · Novartis Europharm Limited